| Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca |
ACTRN12622001217796: A Randomised Controlled Trial of the efficacy and safety of an Inhaled Corticosteroid and Long Acting Beta Agonist maintenance and/or reliever therapy versus standard maintenance with separate reliever therapy in children with mild, moderate and severe asthma. |
|
|
| Recruiting | 3 | 400 | | | Medical Research Institute of New Zealand, AstraZeneca Ltd | Asthma | | | | |
NCT00646529: Long-Term Safety of Symbicort in Asthmatic Children - SAPLING |
|
|
| Completed | 3 | 175 | US | budesonide/formoterol (Symbicort), Symbicort, budesonide (Pulmicort), Pulmicort | AstraZeneca | Asthma | | 10/03 | | |
| Completed | 3 | 430 | US, RoW | budesonide, Pulmicort | AstraZeneca | Asthma | 09/04 | 09/04 | | |
| Completed | 3 | 525 | US, RoW | budesonide, Pulmicort, Placebo | AstraZeneca | Asthma | 10/04 | 10/04 | | |
| Completed | 3 | 900 | US | Budesonide, Pulmicort RESPULES, Pulmicort TURBUHALER | AstraZeneca | Asthma | 12/04 | 12/04 | | |
| Completed | 3 | 742 | Europe | Symbicort Turbuhaler, Symbicort pMDI, Pulmicort Turbuhaler | AstraZeneca | Bronchial Asthma | 04/08 | 04/08 | | |
NCT00855959: Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients |
|
|
| Completed | 3 | 108 | Japan | Budesonide, Pulmicort, Pulmicort Turbuhaler | AstraZeneca | Asthma | 08/09 | 08/09 | | |
| Completed | 3 | 450 | | one inhalation of Pulmicort Turbuhaler 200 ug/inhalation ;Oxis Turbuhaler 4.5 ug/inhalation with symptom-driving ;Symbicort Turbuhaler 160/4.5 ug/inhalation with symptom-driving | 1st Affiliated Hospital of SYSU; 2nd and 3rd Affiliated Hospital of SYSU, 1st Affiliated Hospital of SYSU | mild asthma | | | | |
2005-005469-12: A Phase III, randomised, double-blind, double-dummy cross-over study to compare two dry powder inhaled formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, moderate asthma. |
|
|
| Ongoing | 3 | 30 | Europe | Budesonide Test DPI, Pulmicort Turbohaler 200, Test DPI, Reference DPI, Pulmicort Turbohaler 200, Pulmicort Turbohaler 200 | Neolab Limited | Stable, persistent, moderate asthma | | | | |
NCT04215848: As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period |
|
|
| Completed | 3 | 31 | RoW | Budesonide/Formoterol Fumarate 160 MCG-4.5 MCG Inhalation Powder, Symbicort Turbuhaler (160/4.5 ug), Budesonide 200Mcg Inhalation Powder, Pulmicort Turbuhaler (200 ug) | Hat Yai Medical Education Center | Asthma | 10/21 | 05/22 | | |
